Total planned funding: $180,823,586
Allocations
Countries/Regions
India | $180,823,586 |
Organizational Types
Unknown | $82,355,388 |
NGO | $50,536,859 |
Own Agency | $24,368,542 |
University | $15,290,217 |
Private Contractor | $3,348,272 |
Multi-lateral Agency | $2,406,808 |
FBO | $1,100,000 |
Host Country Government Agency | $1,010,200 |
Other USG Agency | $407,300 |
Program Areas
Governance and Systems | $63,514,089 |
Prevention | $46,763,940 |
Care | $26,463,421 |
Management and Operations | $19,290,763 |
Testing | $11,228,212 |
Treatment | $9,135,369 |
Budget Codes
OHSS: Health Systems Strengthening | $37,941,172 |
HVOP: Sexual Prevention: Other Sexual Prevention | $25,146,472 |
HVSI: Strategic Information | $21,132,752 |
HBHC: Care: Adult Care and Support | $19,372,220 |
HVMS: Management and Operations | $19,290,763 |
HVCT: Testing: HIV Testing and Counseling | $11,228,212 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,161,767 |
HTXS: Treatment: Adult Treatment | $8,825,098 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,163,081 |
HKID: Care: Orphans and Vulnerable Children | $4,654,276 |
HLAB: Laboratory Infrastructure | $4,440,165 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,252,379 |
HVTB: Care: TB/HIV | $2,246,908 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDTX: Treatment: Pediatric Treatment | $286,794 |
PDCS: Care: Pediatric Care and Support | $190,017 |
HTXD: Treatment: ARV Drugs | $23,477 |
Top Partner Programs
Not Available:
$81,307,899
Countries/Regions
FHI 360:
$16,582,311
Countries/Regions
USG Aggregated Agencies:
$14,996,527
Countries/Regions
Voluntary Health Services:
$10,140,000
Countries/Regions